ASND Competitors & Alternatives
Compare Ascendis Pharma AS with similar stocks in the same industry
Biotechnology
ASND
Main Stock$238.90
Tradestie Score
51
Market Cap
$12.36B
P/E Ratio
17.6
Revenue Growth
1.1%
Analyst Upside
+28.8%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$39.57
|
$19.56B | 30.8 | 43 | Compare |
|
INCY
Incyte Genomics Inc
|
$113.44
|
$16.93B | 14.9 | 76 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$62.15
|
$15.70B | 33.1 | 44 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.83
|
$15.22B | - | 49 | Compare |
|
EXEL
Exelixis Inc
|
$64.58
|
$11.09B | 20.3 | 38 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.80
|
$10.76B | - | 62 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$245.81
|
$10.74B | - | 35 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$55.21
|
$10.53B | 152.5 | 72 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$44.27
|
$10.49B | - | 69 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$67.74
|
$10.22B | - | 70 | Compare |
More ASND Analysis
Data updated: Oct 21, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry